AIMS: Heart failure is known to profoundly affect health-related quality of life (HRQoL). We aimed to describe both generic and disease-specific HRQoL in a large community-based sample of patients with systolic heart failure (SHF) and to identify important somatic and psychosocial correlates. METHODS AND RESULTS: Seven hundred and two patients, 67 ± 12 years old, 71 % men, with distributions of New York Heart Association (NYHA) functional classes I/II/III/IV of 2/55/39/4 % were included in this cross-sectional analysis. Generic HRQoL was measured with the SF-36 health survey, disease-specific HRQoL with the Kansas City Cardiomyopathy Questionnaire, and depression with the self-reported Patient Health Questionnaire (PHQ-9). Both generic- and disease-specific HRQoL measurements indicated moderate to poor HRQoL. The KCCQ scores demonstrated higher sensitivity to the varying levels of heart failure severity as compared to the SF-36 scores. Patients with either a minor (15 %) or a major depression (24 %) reported significantly and substantially lower HRQoL (p < .001) than patients without depression did. In multivariable regression analyses, depression accounted for the largest part of the variance of both generic and specific HRQoL (12 and 36 %, respectively), whereas most biomedical variables had no or only a marginal influence. CONCLUSION: Patients with SHF suffer from severe limitations of HRQoL. Depression was the most important correlate of both generic and disease-specific HRQoL.
AIMS: Heart failure is known to profoundly affect health-related quality of life (HRQoL). We aimed to describe both generic and disease-specific HRQoL in a large community-based sample of patients with systolic heart failure (SHF) and to identify important somatic and psychosocial correlates. METHODS AND RESULTS: Seven hundred and two patients, 67 ± 12 years old, 71 % men, with distributions of New York Heart Association (NYHA) functional classes I/II/III/IV of 2/55/39/4 % were included in this cross-sectional analysis. Generic HRQoL was measured with the SF-36 health survey, disease-specific HRQoL with the Kansas City Cardiomyopathy Questionnaire, and depression with the self-reported Patient Health Questionnaire (PHQ-9). Both generic- and disease-specific HRQoL measurements indicated moderate to poor HRQoL. The KCCQ scores demonstrated higher sensitivity to the varying levels of heart failure severity as compared to the SF-36 scores. Patients with either a minor (15 %) or a major depression (24 %) reported significantly and substantially lower HRQoL (p < .001) than patients without depression did. In multivariable regression analyses, depression accounted for the largest part of the variance of both generic and specific HRQoL (12 and 36 %, respectively), whereas most biomedical variables had no or only a marginal influence. CONCLUSION:Patients with SHF suffer from severe limitations of HRQoL. Depression was the most important correlate of both generic and disease-specific HRQoL.
Authors: Christiane E Angermann; Stefan Störk; Götz Gelbrich; Hermann Faller; Roland Jahns; Stefan Frantz; Markus Loeffler; Georg Ertl Journal: Circ Heart Fail Date: 2011-09-28 Impact factor: 8.790
Authors: T S Rector; G Johnson; W B Dunkman; G Daniels; L Farrell; A Henrick; B Smith; J N Cohn Journal: Circulation Date: 1993-06 Impact factor: 29.690
Authors: Susan J Bennet; Neil B Oldridge; George J Eckert; Jennifer L Embree; Sherry Browning; Nan Hou; Melissa Deer; Michael D Murray Journal: Qual Life Res Date: 2002-06 Impact factor: 4.147
Authors: Wei Jiang; Maragatha Kuchibhatla; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor Journal: Am Heart J Date: 2007-07 Impact factor: 4.749
Authors: Maxie Bunz; Denise Lenski; Sonja Wedegärtner; Christian Ukena; Julia Karbach; Michael Böhm; Ingrid Kindermann Journal: Clin Res Cardiol Date: 2015-10-19 Impact factor: 5.460
Authors: Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran Journal: Can J Psychiatry Date: 2016-08-02 Impact factor: 4.356
Authors: Marie Dorow; Janine Stein; Alexander Pabst; Siegfried Weyerer; Jochen Werle; Wolfgang Maier; Lisa Miebach; Martin Scherer; Anne Stark; Birgitt Wiese; Lilia Moor; Jens-Oliver Bock; Hans-Helmut König; Steffi G Riedel-Heller Journal: Int J Methods Psychiatr Res Date: 2017-09-25 Impact factor: 4.035
Authors: Kenneth E Freedland; Robert M Carney; Michael W Rich; Brian C Steinmeyer; Eugene H Rubin Journal: JAMA Intern Med Date: 2015-11 Impact factor: 21.873
Authors: Ulrich Tebbe; Carsten Tschöpe; Jost Henner Wirtz; Jan Lokies; Eva Turgonyi; Peter Bramlage; Anke M Strunz; Katharina Lins; Michael Böhm Journal: Clin Res Cardiol Date: 2014-02-18 Impact factor: 5.460